Functionally, these soluble isoforms of NRP1 were reported to bind VEGF-A165, although not VEGF-A121, thus inhibiting VEGF-A165-induced phosphorylation of VEGFR-2 in endothelial cells resulting in reduced tumor growth (anti-tumor properties) [133]. The gene discussed is NRP1; the disease is neoplasm.